STOCK TITAN

Selectis Health Inc Stock Price, News & Analysis

GBCS OTC

Welcome to our dedicated page for Selectis Health news (Ticker: GBCS), a resource for investors and traders seeking the latest updates and insights on Selectis Health stock.

Selectis Health Inc (GBCS) operates at the intersection of healthcare administration and specialized real estate, managing facilities that serve critical care needs. This page aggregates official updates about property transactions, regulatory compliance milestones, and operational developments within the company.

Investors and industry observers will find timely reports on earnings, facility acquisitions/dispositions, and management changes. All content is sourced directly from verified corporate communications to ensure accuracy and relevance for strategic decision-making.

Key updates include healthcare property sales, lease administration developments, and strategic initiatives through subsidiaries like Goodwill Hunting, LLC. The curated collection enables tracking of how GBCS navigates both real estate markets and healthcare regulations.

Bookmark this page for streamlined access to Selectis Health's latest business moves. Check back regularly for updates that reflect the company's unique position in healthcare infrastructure management.

News
Rhea-AI Summary

Selectis Health, Inc. (OTC: GBCS) reported a revenue increase of over 75% year-over-year for Q1 2022. The company has improved patient census across its facilities while facing delays in financial audits. Interim CFO Christine Lucus has been appointed, and David Furstenberg joins the Board of Directors to enhance corporate governance. Selectis has secured direct billing approvals for all its facilities and aims to eliminate third-party staffing needs by year-end 2022. The company is focused on operational upgrades and maximizing profitability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25.93%
Tags
none
-
Rhea-AI Summary

Selectis Health, Inc. (OTC: GBCS) has announced a postponement of its scheduled conference call on April 26, 2022, due to additional time needed to finalize the audit of its 2021 financial statements. The company is committed to reporting its fourth quarter and full year 2021 financial results as soon as possible. An update on the timing for the rescheduled conference call will be provided within the next few business days. Selectis operates healthcare facilities across several states, focusing on improving the quality of care for residents.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Selectis Health (OTC: GBCS) will host a conference call on April 26, 2022, at 4:30 p.m. ET to discuss its financial results for Q4 and FY 2021. A press release detailing the results will precede the call. Interested parties can join by dialing 1-877-704-4453 (toll-free) or 1-201-389-0920 (international) and using Conference ID: 13727317. A replay will be available after 7:30 p.m. ET on the same day until May 10, 2022. Selectis Health provides a variety of healthcare services across several states, focusing on strategic community partnerships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.11%
Tags
none
Rhea-AI Summary

Selectis Health has engaged Gateway Group to enhance its investor relations initiatives. This partnership aims to improve corporate messaging, develop outreach programs, and facilitate connections with institutional investors and analysts. CEO Lance Baller emphasized the strategic timing following operational progress in 2021 and a completed rebranding. The collaboration aims to promote Selectis' growth story to a broader audience and enhance market awareness as it seeks to deepen its presence in the Southcentral and Southeastern U.S. healthcare markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
partnership
-
Rhea-AI Summary

Selectis Health reported a net loss of $0.06 million for Q3 2021, equating to $(0.02) per diluted share, a decline from a net income of $0.46 million in Q3 2020. Despite this, total revenue rose by 15.8% year-over-year to $7.32 million. Key developments included a $750,000 fund raise, a 1-for-10 reverse stock split, and refinancing of the Southern Hills mortgage at 2.38% for 35 years. The company faced challenges with COVID-related staffing shortages, incurring $532,030 in agency staffing expenses. Selectis anticipates improved results in 2022 as operational adjustments take effect.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Selectis Health, Inc. (OTC: GBCS) is set to release its third-quarter 2021 financial results on November 16, 2021. A shareholder call will take place on the same day at 4:15 PM EST, where management will discuss the company's performance. Interested parties can join the call by dialing (877)-705-6003 and using confirmation number 13725159. A replay will be available until November 30, 2021. Selectis operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing various rehabilitation and health services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.92%
Tags
Rhea-AI Summary

Selectis Health, Inc. (OTC: GBCSD) announced the successful refinancing of its Southern Hills Continuing Care Retirement Community (CCRC) with a loan of $8,029,800 at a fixed interest rate of 2.38% for 35 years. This refinance supports the facility’s profitability and operational consistency. The company also appointed a new Executive Director to oversee improvements, including renovations that enhance living conditions for residents. Future refinancing efforts for the Eastman facility are underway, promising further positive developments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.4%
Tags
none
-
Rhea-AI Summary

Selectis Health, Inc. (formerly Global Healthcare REIT, Inc.) is set to implement a 1-for-10 reverse stock split effective September 22, 2021. This move aims to enhance market visibility and attract institutional investors, with the company’s shares reducing from approximately 29 million to 2.9 million. The new ticker symbol remains GBCS, and a 'D' will be added to the symbol for 20 business days to denote the reverse split. Shareholders will receive instructions for exchanging certificates, with a $50 fee for manual changes. This strategic decision aligns with the company's objectives to satisfy NYSE listing requirements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.17%
Tags
none
-
Rhea-AI Summary

Selectis Health, Inc. (OTC: GBCS) reported a net loss of $(686,280) or $(0.03) per diluted share for Q2 2021, compared to net income of $1,116,055 or $0.04 per diluted share one year prior. Despite this, total revenues increased by 17.2% to $6.01 million in Q2 2021 from $5.13 million in Q2 2020. The company completed a significant rebranding and transition of its operations, increasing occupancy by 30% at its independent living facility. However, the impact of COVID-19 and unexpected repair costs have negatively affected census and staffing operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

On August 14, 2021, Selectis Health, formerly Global Healthcare REIT, announced it will release its second quarter 2021 financial results on August 16, 2021. The company operates Assisted Living, Independent Living, and Skilled Nursing facilities across Arkansas, Georgia, Ohio, and Oklahoma, offering various healthcare services. Investors are encouraged to join the shareholder call at 4:15 PM EDT on the same day for insights into the company's performance. Additional details for joining the teleconference were provided, along with information for a replay.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the current stock price of Selectis Health (GBCS)?

The current stock price of Selectis Health (GBCS) is $2 as of May 2, 2025.

What is the market cap of Selectis Health (GBCS)?

The market cap of Selectis Health (GBCS) is approximately 6.9M.
Selectis Health Inc

OTC:GBCS

GBCS Rankings

GBCS Stock Data

6.90M
2.38M
22.28%
Medical Care Facilities
Healthcare
Link
United States
Greenwood Village